BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19039515)

  • 1. Testing thermal resistance of viruses.
    Sauerbrei A; Wutzler P
    Arch Virol; 2009; 154(1):115-9. PubMed ID: 19039515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virucidal efficacy of povidone-iodine-containing disinfectants.
    Sauerbrei A; Wutzler P
    Lett Appl Microbiol; 2010 Aug; 51(2):158-63. PubMed ID: 20536707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products.
    Welch J; Bienek C; Gomperts E; Simmonds P
    Transfusion; 2006 Nov; 46(11):1951-8. PubMed ID: 17076851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Virucidal effectiveness of some commercial products for chemothermal disinfection methods for temperature resistant viruses and bacteriophages--evaluation of a test model].
    von Rheinbaben F; Bansemir KP; Heinzel M
    Zentralbl Hyg Umweltmed; 1992 Feb; 192(5):419-31. PubMed ID: 1313238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus inactivation and protein recovery in a novel ultraviolet-C reactor.
    Wang J; Mauser A; Chao SF; Remington K; Treckmann R; Kaiser K; Pifat D; Hotta J
    Vox Sang; 2004 May; 86(4):230-8. PubMed ID: 15144527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.
    Borovec S; Broumis C; Adcock W; Fang R; Uren E
    Biologicals; 1998 Sep; 26(3):237-44. PubMed ID: 10208725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on thermal resistance of bovine parvovirus against moist and dry heat.
    Bräuniger S; Peters J; Borchers U; Kao M
    Int J Hyg Environ Health; 2000 Mar; 203(1):71-5. PubMed ID: 10956592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of parvovirus B19 and model viruses in factor VIII by dry heat treatment at 80 degrees C.
    Roberts PL; El Hana C; Saldana J
    Transfusion; 2006 Sep; 46(9):1648-50; author reply 1650. PubMed ID: 16965597
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the inactivation of canine and bovine parvovirus by freeze-drying and dry-heat treatment in two high purity factor VIII concentrates.
    Roberts PL; Hart H
    Biologicals; 2000 Sep; 28(3):185-8. PubMed ID: 10964445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of virus safety of a S/D-treated factor VIII concentrate by additional dry heat treatment at 100 degrees C.
    Dichtelmüller H; Rudnick D; Breuer B; Kotitschke R; Kloft M; Darling A; Watson E; Flehmig B; Lawson S; Frösner G
    Biologicals; 1996 Jun; 24(2):125-30. PubMed ID: 8889059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inactivation of BVDV (experimental model for hepatitis C) using low pH and heat treatment in intravenous human immunoglobulins].
    Ruibal Brunet IJ; Noa Romero E; Rivero Mas AT; Martín García RZ
    Sangre (Barc); 1999 Oct; 44(5):352-6. PubMed ID: 10618912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus inactivation in albumin by a combination of alkali conditions and high temperature.
    Roberts PL; More J; Rott J; Lewin D
    Biologicals; 2011 Mar; 39(2):67-72. PubMed ID: 21333548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel method of inactivation of human immunodeficiency virus type 1 by the freeze pressure generation method.
    Otake T; Kawahata T; Mori H; Kojima Y; Hayakawa K
    Appl Microbiol Biotechnol; 2005 Jun; 67(6):746-51. PubMed ID: 15700126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disinfection efficacy against parvoviruses compared with reference viruses.
    Eterpi M; McDonnell G; Thomas V
    J Hosp Infect; 2009 Sep; 73(1):64-70. PubMed ID: 19646784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of manufacturing process parameters on virus inactivation by dry heat treatment at 80 degrees C in factor VIII.
    Roberts PL; Dunkerley C; McAuley A; Winkelman L
    Vox Sang; 2007 Jan; 92(1):56-63. PubMed ID: 17181591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydrostatic pressure on the stability and thermostability of poliovirus: a new method for vaccine preservation.
    Ferreira E; Mendes YS; Silva JL; Galler R; Oliveira AC; Freire MS; Gaspar LP
    Vaccine; 2009 Aug; 27(39):5332-7. PubMed ID: 19616496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The temperature stability of bovine parvovirus].
    Bräuniger S; Fischer I; Peters J
    Zentralbl Hyg Umweltmed; 1994 Oct; 196(3):270-8. PubMed ID: 7848502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterisation of poliovirus mutants resistant to heating at 50 degrees Celsius for 30 min.
    Shiomi H; Urasawa T; Urasawa S; Kobayashi N; Abe S; Taniguchi K
    J Med Virol; 2004 Nov; 74(3):484-91. PubMed ID: 15368512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.